Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06434272 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture

Study acronym: BEAN
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revisedv8
  2. Eligibility criteria expanded, about 14 words
    • Site details revised
    v7
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jan 9, 2026 to Jan 9, 2028
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 2025 to Jan 28, 2025
    v6
  4. Study Identification, Study Status, Oversight, Outcome Measuresv5
  5. Interventions: Exercise with partial Blood Flow Restriction (Other) to Early exercise with partial Blood Flow Restriction (Other), Late exercise with partial Blood Flow Restriction (Other)
    • Secondary endpoints revised (9)
    • Eligibility criteria expanded, about 3 words
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Collaborators reorderedv3
  2. Start date: Aug 1, 2024 to Feb 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to gain insights into the effects of Blood Flow Restriction Exercise (BFRE) in patients with an acute Achilles tendon Rupture. The main questions it aims to answer are: Is BFRE an effective adjunct to usual care when compared with only usual care? When is the optimal timing for initiating BFRE: In the early treatment stage or at the later stage after hospital treatment? Participants will receive an intervention comprising 12 weeks of BFRE as an adjunct to usual care. * Either in the initial 1-12 weeks after Achilles tendon rupture, or * In the following 13-24 weeks after Achilles tendon rupture Researchers will compare the two groups at 13 weeks (3 months) to compare BFRE to usual care, and at 25 weeks (6 months) to compare the two time points for initiating BFRE (early vs. late).
Trial Details
NCT Number NCT06434272
Lead Sponsor University of Aarhus
Collaborators: Aarhus University Hospital, Aalborg University Hospital, Gødstrup Hospital, Regionshospitalet Horsens
Conditions
(from sponsor)		 Achilles Tendon Rupture
Enrollment 218 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov